Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

3827 ARTÍCULOS , VIENDO DEL 1141 AL 1155

Encapsulation of antioxidants in gastrointestinal-resistant nanoparticulate carriers

Souto EB, Severino P, Basso R, Santana MH.

Methods Mol Biol. 2013;1028:37-46. doi: 10.1007/978-1-62703-475-3_3.

Moving from physician-centered care towards patient-centered care for Parkinson's disease patients

van der Eijk M, Nijhuis FA, Faber MJ, Bloem BR.

Parkinsonism Relat Disord. 2013 Nov;19(11):923-7. doi: 10.1016/j.parkreldis.2013.04.022. Epub 2013 Jun 3.

Reprint of: revisiting oxidative stress and mitochondrial dysfunction in the pathogenesis of Parkinson disease-resemblance to the effect of amphetamine drugs of abuse

Perfeito R, Cunha-Oliveira T, Rego AC.

Free Radic Biol Med. 2013 Sep;62:186-201. doi: 10.1016/j.freeradbiomed.2013.05.042. Epub 2013 Jun 3.

Targeted training of the decision rule benefits rule-guided behavior in Parkinson's disease

Ell SW.

Cogn Affect Behav Neurosci. 2013 Dec;13(4):830-46. doi: 10.3758/s13415-013-0176-4.

Cabergoline use and risk of fibrosis and insufficiency of cardiac valves. Meta-analysis of observational studies

De Vecchis R, Esposito C, Ariano C.

Herz. 2013 Dec;38(8):868-80. doi: 10.1007/s00059-013-3816-0. Epub 2013 Jun 8.

Active inference, sensory attenuation and illusions

Brown H, Adams RA, Parees I, Edwards M, Friston K.

Cogn Process. 2013 Nov;14(4):411-27. doi: 10.1007/s10339-013-0571-3. Epub 2013 Jun 7.

Evaluation of Parkinson disease and Alzheimer disease with the use of neuromelanin MR imaging and (123)I-metaiodobenzylguanidine scintigraphy

Miyoshi F, Ogawa T, Kitao SI, Kitayama M, Shinohara Y, Takasugi M, Fujii S, Kaminou T.

AJNR Am J Neuroradiol. 2013 Nov-Dec;34(11):2113-8. doi: 10.3174/ajnr.A3567. Epub 2013 Jun 6.

Markedly asymmetric presentation in multiple system atrophy

Batla A, Stamelou M, Mensikova K, Kaiserova M, Tuckova L, Kanovsky P, Quinn N, Bhatia KP.

Parkinsonism Relat Disord. 2013 Oct;19(10):901-5. doi: 10.1016/j.parkreldis.2013.05.004. Epub 2013 Jun 6.

Comparison of quantitative EEG between patients with Alzheimer's disease and those with Parkinson's disease dementia

Fonseca LC, Tedrus GM, Carvas PN, Machado EC.

Clin Neurophysiol. 2013 Oct;124(10):1970-4. doi: 10.1016/j.clinph.2013.05.001. Epub 2013 Jun 5.

A new mutation of the fukutin gene causing late-onset limb girdle muscular dystrophy

Riisager M, Duno M, Hansen FJ, Krag TO, Vissing CR, Vissing J.

Neuromuscul Disord. 2013 Jul;23(7):562-7. doi: 10.1016/j.nmd.2013.04.006. Epub 2013 Jun 6.

Association between PARK16 and Parkinson's disease in the Han Chinese population: a meta-analysis

Chang KH, Chen CM, Chen YC, Lyu RK, Chang HS, Ro LS, Lee-Chen GJ, Wu YR.

Neurobiol Aging. 2013 Oct;34(10):2442.e5-9. doi: 10.1016/j.neurobiolaging.2013.04.028. Epub 2013 Jun 5.

Applying chaperones to protein-misfolding disorders: molecular chaperones against α-synuclein in Parkinson's disease

Chaari A, Hoarau-Véchot J, Ladjimi M.

Int J Biol Macromol. 2013 Sep;60:196-205. doi: 10.1016/j.ijbiomac.2013.05.032. Epub 2013 Jun 5.

Caring for parents with neurodegenerative disease: a qualitative description

Habermann B, Hines D, Davis L.

Clin Nurse Spec. 2013 Jul-Aug;27(4):182-7. doi: 10.1097/NUR.0b013e318295576b.

Low-frequency subthalamic nucleus deep brain stimulation for axial symptoms in advanced Parkinson's disease

Sidiropoulos C, Walsh R, Meaney C, Poon YY, Fallis M, Moro E.

J Neurol. 2013 Sep;260(9):2306-11. doi: 10.1007/s00415-013-6983-2. Epub 2013 Jun 9.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias